The new HEVA Pro white paper is now available!

The new HEVA Pro white paper explores the full potential of this advanced targeted capture panel based on Next Generation Sequencing (NGS) technology, designed for comprehensive analysis of genes associated with hereditary and somatic cancer predisposition. The white paper details the technology, validation, and clinical applications of HEVA Pro, aligned with NCCN guidelines, highlighting its accuracy and reliability even with complex samples.

👉 Download it now to discover how HEVA Pro supports early diagnosis, personalized patient management, and advanced oncology research.

Share:

More Posts